Chandra, Shruti http://orcid.org/0000-0002-2634-9775
Tan, Emanuel Yuquan
Empeslidis, Theo
Sivaprasad, Sobha
Article History
Received: 19 March 2023
Revised: 2 May 2023
Accepted: 26 May 2023
First Online: 7 June 2023
Competing interests
: S.S. has received funding/fees from Bayer, Novartis, Abbvie, Roche, Boehringer Ingelheim, Optos, EyeBiotech, Biogen, and Apellis. T.E. is an employee of Boehringer Ingelheim Ltd, Germany. S.S. and S.C. are members of the Eye editorial board.